<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>115(1)</volume><submitter>Kim CG</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Among colorectal cancers (CRCs), high-frequency microsatellite instability (MSI-H) is associated with a better prognosis, compared with low-frequency MSI or microsatellite stability (MSI-L/MSS). However, it is unclear whether MSI affects the prognosis of recurrent CRCs.&lt;h4>Methods&lt;/h4>This study included 2940 patients with stage I-III CRC who underwent complete resection. The associations of MSI status with recurrence patterns, disease-free survival (DFS), overall survival from diagnosis to death (OS1), and overall survival from recurrence to death (OS2) were analysed.&lt;h4>Results&lt;/h4>A total of 261 patients (8.9%) had MSI-H CRC. Patients with MSI-H CRC had better DFS, compared to patients with MSI-L/MSS CRC (hazard ratio (HR): 0.619, P&lt;0.001). High-frequency microsatellite instability CRC was associated with more frequent local recurrence (30.0% vs 12.0%, P=0.032) or peritoneal metastasis (40.0% vs 12.3%, P=0.003), and less frequent lung (10.0% vs 42.5%, P=0.004) or liver metastases (15.0% vs 44.7%, P=0.01). Recurrent MSI-H CRC was associated with worse OS1 (HR: 1.363, P=0.035) and OS2 (HR: 2.667, P&lt;0.001). An analysis of patients with colon cancer yielded similar results.&lt;h4>Conclusions&lt;/h4>Recurrence patterns differed between MSI-H CRC and MSI-L/MSS CRC, and recurrent MSI-H CRCs had a worse prognosis.</pubmed_abstract><journal>British journal of cancer</journal><pagination>25-33</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4931375</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.</pubmed_title><pmcid>PMC4931375</pmcid><pubmed_authors>Kim CG</pubmed_authors><pubmed_authors>Kim C</pubmed_authors><pubmed_authors>Min BS</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Ahn JB</pubmed_authors><pubmed_authors>Shin SJ</pubmed_authors><pubmed_authors>Park HS</pubmed_authors><pubmed_authors>Koom WS</pubmed_authors><pubmed_authors>Beom SH</pubmed_authors><pubmed_authors>Kim JH</pubmed_authors><pubmed_authors>Heo SJ</pubmed_authors><pubmed_authors>Jung M</pubmed_authors><pubmed_authors>Kim NK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.</name><description>&lt;h4>Background&lt;/h4>Among colorectal cancers (CRCs), high-frequency microsatellite instability (MSI-H) is associated with a better prognosis, compared with low-frequency MSI or microsatellite stability (MSI-L/MSS). However, it is unclear whether MSI affects the prognosis of recurrent CRCs.&lt;h4>Methods&lt;/h4>This study included 2940 patients with stage I-III CRC who underwent complete resection. The associations of MSI status with recurrence patterns, disease-free survival (DFS), overall survival from diagnosis to death (OS1), and overall survival from recurrence to death (OS2) were analysed.&lt;h4>Results&lt;/h4>A total of 261 patients (8.9%) had MSI-H CRC. Patients with MSI-H CRC had better DFS, compared to patients with MSI-L/MSS CRC (hazard ratio (HR): 0.619, P&lt;0.001). High-frequency microsatellite instability CRC was associated with more frequent local recurrence (30.0% vs 12.0%, P=0.032) or peritoneal metastasis (40.0% vs 12.3%, P=0.003), and less frequent lung (10.0% vs 42.5%, P=0.004) or liver metastases (15.0% vs 44.7%, P=0.01). Recurrent MSI-H CRC was associated with worse OS1 (HR: 1.363, P=0.035) and OS2 (HR: 2.667, P&lt;0.001). An analysis of patients with colon cancer yielded similar results.&lt;h4>Conclusions&lt;/h4>Recurrence patterns differed between MSI-H CRC and MSI-L/MSS CRC, and recurrent MSI-H CRCs had a worse prognosis.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2025-04-06T19:42:17.047Z</modification><creation>2019-03-27T02:17:28Z</creation></dates><accession>S-EPMC4931375</accession><cross_references><pubmed>27228287</pubmed><doi>10.1038/bjc.2016.161</doi></cross_references></HashMap>